Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Curvebeam AI Ltd. (CVB) vs. Competitors

14 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:CVBCurvebeam AI Ltd.AUD 0.02AUD 13.87M-0.38-78.08%―Unlock the AU:CVB analyst price target with TipRanks PremiumAU:CVBUnlock the AU:CVB top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.26AUD 61.10M-6.84-17.46%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumAU:CVB vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:SHGSingular Health Group LtdAUD 0.18AUD 61.96M-8.62-32.08%Moderate BuyUnlock the AU:SHG analyst price target with TipRanks PremiumAU:CVB vs AU:SHGUnlock the AU:SHG top-analyst price target with TipRanks Premium
AU:AYAArtrya LimitedAUD 2.70AUD 443.94M-14.77-14.56%Strong BuyUnlock the AU:AYA analyst price target with TipRanks PremiumAU:CVB vs AU:AYAUnlock the AU:AYA top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 1.20AUD 168.73M71.188.64%Moderate BuyUnlock the AU:ALC analyst price target with TipRanks PremiumAU:CVB vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium
AU:4DX4DMedical LtdAUD 2.15AUD 1.30B-5.6744.78%Moderate BuyUnlock the AU:4DX analyst price target with TipRanks PremiumAU:CVB vs AU:4DXUnlock the AU:4DX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:CVBCurvebeam AI Ltd.0.02-0.06-77.78%
AU:M7TMach7 Technologies0.26-0.09-25.71%
AU:SHGSingular Health Group Ltd0.18-0.10-34.55%
AU:AYAArtrya Limited2.70-0.47-14.83%
AU:ALCAlcidion Group Limited1.200.2019.50%
AU:4DX4DMedical Ltd2.150.6947.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts